Navigation Links
Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations
Date:11/8/2007

Fong will lead sales and marketing of CTI products

SEATTLE, Nov. 8 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTAX: CTIC) announced today that Jim Fong has been appointed the company's Vice President, Commercial Operations. Fong joins CTI with more than 20 years of sales and marketing experience. Most recently, Fong was National Sales Director at CV Therapeutics (CVT) in Palo Alto, California, where he led the launch of Ranexa(R) for chronic angina. CTI recently agreed to acquire the drug ZEVALIN(R) from Biogen Idec for development, marketing, and sale in the United States. Closing of the acquisition, which remains subject to closing conditions including obtaining certain third party consents, is expected in mid-November.

"Jim did a great job at the launch of Ranexa and streamlining CVT's commercial operations. With his prior expertise in marketing and sales, and the launch of a novel blockbuster anti-cancer agent Camptosar(R), Jim has the ideal credentials to positively impact the ZEVALIN relaunch while optimizing the positioning of our future oncology products like pixantrone," noted James A. Bianco, M.D., President and CEO of CTI.

Fong, who will report directly to Dr. Bianco, will be in charge of directing the sales and promotion of CTI products at the national and international levels. This will include product positioning, promotional programs, reimbursement strategies, and development and training of a national sales force.

"I am very pleased to join the CTI team and help re-establish a strong sales and marketing presence for the company," said Fong. "ZEVALIN is a great product and CTI is on an upward growth path with multiple opportunities for product launches in the coming years."

At CVT, Fong managed a sales team of more than 200 people, including business managers, marketing and sales operations, and the sales training department. Prior to CVT, Fong directed several sales teams and als
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
2. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
3. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
4. Cell Therapeutics, Inc. (CTI) CIBC and Rodman & Renshaw Healthcare Conference Presentations to be Webcast
5. Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 8
6. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results
7. WorldHeart Appoints David Pellone Chief Financial Officer
8. Novo Nordisk Appoints New Leader of North American Business
9. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
10. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
11. Resonant Medical Appoints New Vice President of Global Sales

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009).... 30 - Salon Leau announced today t...mber 7(th) to raise funds and create positive impa...s. All proceeds from each haircut and or color wil...tal. ,, Salon Leau has been serving the posh W...y LoAnn Lai, widely recognized for her innovation ...
(Date:11/30/2009)....J., Nov. 30 Advanced Health Media...logistics, speaker programs and commercial complia...stry, announced it has been named the second faste...ey,s leading statewide business newspaper. AHM wa...have made significant contributions to the state,s...
(Date:11/30/2009)...ease Control and Prevention estimate that well ove...cted with HIV/AIDS. New research from North Caroli...ted are minorities and do not have health insuranc... to facilitate education and prevention efforts in...arch, which analyzed 90,000 HIV patient hospital v...
(Date:11/30/2009)...gravy and dessert at the holiday table are even le...ught. According to a new research report recently ...ww.fasebj.org ), a diet that is high in fat and in...cause our bodies to store too much fat. This means...lready difficult task of converting high-fat and h...
(Date:11/30/2009)...Peter J. Rappa, MD, explores the intricate connect..."Healing Heart to Soul: One Doctor’s Jo...oks 2009). , Dallas, TX (...sing to let go of negative emotions, whether cause... our shoulders. Oftentimes, this disease of the hu...
Breaking Medicine News(10 mins):Health News:Georgetown Hair Salon Helps St. Jude Find A Cure 2Health News:Advanced Health Media Honored at NJ Finest Award Ceremony 2Health News:Research highlights need for national HIV strategy 2Health News:Western diets turn on fat genes 2Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2
... Germany, October 17 - For the Nine Months (to 3...ine Months Almost Six-Fold Growth in EBIT to EUR34...ITDA by 50% to EUR124m - Substantial Debt Reducti...rst nine months of its financial year (to 31 Augus...
...ethicillin-resistant Staphylococcus aureus Infecti...sed MRSA infections are about triple, previous es...ntion have,consistently understated the size of th...W YORK, Oct. 17 Today, data in an article,publish...
... Oct. 16 The following is a,transcript of remarks...,Donna Shalala., THE PRESIDENT: Good afternoon. T...preciate Senator Dole and Secretary Shalala and ot...field -- with service members who were rebuilding ...
...it Club expert/bestselling author Dr. Ian Smith br...Oakland; Stars come out for free afternoon o...OAKLAND, Calif., Oct. 16 Dr. Ian Smith,s 50 Milli...,lives across the community. Backed by African-Ame...
... Oct. 16 Speaker Nancy Pelosi,Senate Majority Lea... by,singer Paul Simon, Families USA, Easter Seals,...ning to urge Members of Congress to override the,P...Seals, and to the,representatives of the many orga...
...ct. 16 As the race to the 2008 elections,heats up...proposal for,providing health care coverage. "But... quality of,health care companies, the debt burden... & Poor,s Ratings Services,in a report published O...
Other Medicine News:Health News:Growth Trend for Gerresheimer Continues Unabated - Debt Reduction 2Health News:Growth Trend for Gerresheimer Continues Unabated - Debt Reduction 3Health News:Growth Trend for Gerresheimer Continues Unabated - Debt Reduction 4Health News:Growth Trend for Gerresheimer Continues Unabated - Debt Reduction 5Health News:The Journal of the American Medical Association (JAMA) Article Reveals Scope of MRSA Infections 2Health News:Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for America's Returning Wounded Warriors Report Implementation 2Health News:Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for America's Returning Wounded Warriors Report Implementation 3Health News:Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for America's Returning Wounded Warriors Report Implementation 4Health News:Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for America's Returning Wounded Warriors Report Implementation 5Health News:Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for America's Returning Wounded Warriors Report Implementation 6Health News:Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for America's Returning Wounded Warriors Report Implementation 7Health News:Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for America's Returning Wounded Warriors Report Implementation 8Health News:Challenge Tops 848,000 lbs, Urges Oaklanders to Team Up to Fight Epidemic of Excess Weight 2Health News:Challenge Tops 848,000 lbs, Urges Oaklanders to Team Up to Fight Epidemic of Excess Weight 3Health News:Challenge Tops 848,000 lbs, Urges Oaklanders to Team Up to Fight Epidemic of Excess Weight 4Health News:Pelosi: In 48 Hours, Congress Must Choose Between Meeting the Needs of America's Children or Not 2Health News:S&P: Leverage Tops Politics as Primary Credit Concern for U.S. Health Care Companies, Says S&P 2
(Date:11/30/2009)...JING, Nov. 30 /PRNewswire-Asia-FirstCall/ -- Lotus...("Lotus" or the "Company") a growing developer and...nal seller of pharmaceutical,products in the Peopl... its,Over-the-Counter Drug division ("OTC Division... more than five hundred drug stores in Beijing as ...
(Date:11/30/2009)..., Nov. 30 Stemline Therapeutics, I...mpany and leading developer of oncology compounds ...t The University of Texas M.D. Anderson Cancer Cen... research collaboration. As part of this collabora...II clinical trial of SL-401 in patients with acute...
(Date:11/30/2009)... , ATLANTA, Georgia, November 30 /P...ort (CDS), an internet-based curriculum for direct...by MC Strategies/Elsevier and the, University of M...d today that,its second Disability Intensive Cours...dministrators and learners to use as part of the o...
Breaking Medicine Technology:Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores 2Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores 3Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center 2Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 2Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 3Results From Two Phase II Trials Add to Understanding of Ticagrelor 28BRILINTA 28TM 29 29 and How it Works in the Body 6364 1Results From Two Phase II Trials Add to Understanding of Ticagrelor 28BRILINTA 28TM 29 29 and How it Works in the Body 6364 2Results From Two Phase II Trials Add to Understanding of Ticagrelor 28BRILINTA 28TM 29 29 and How it Works in the Body 6364 3Results From Two Phase II Trials Add to Understanding of Ticagrelor 28BRILINTA 28TM 29 29 and How it Works in the Body 6364 4Is hepatic differentiation of embryonic stem cells induced by valproic acid and cytokines 3F 61615 1No muss no fuss miniaturized analysis for complex samples developed 10786 1No muss no fuss miniaturized analysis for complex samples developed 10786 2No muss no fuss miniaturized analysis for complex samples developed 10786 3
...e Phase 2 Trials in Colorectal Cancer,and in Hormo... FRANCISCO, Calif., June 01, 2007,/PRNewswire-Firs...rmaceutical company focused on oncology, today ann...alysis of two Phase 1,dose-escalating trials of pi...ial first-line treatment of metastatic colorectal ...
...t Lung Cancer Diversity Study, CHICAGO, June 01, 2... cancer is the leading cause of cancer death in,Af... be diagnosed,and 16,700 deaths expected this year...ng cause of cancer death in Hispanic men and the,s...men.(ii),Researchers at Eli Lilly and Company are ...
Other Medicine Technology:Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 2Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 3Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 4Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 5Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 6Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 2Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 3Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 4Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 5Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 6Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 7Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 8Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 9Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 10Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 11
...Anesthesia Monitor (AM) is a multiparameter monito...for routine to the most demanding anesthesia appli...s, you can choose the set of parameters that best ...s evolve, the modularity of the S/5 AM allows you ...
...om, ,The Cardiocap II is a cost-effective solutio...ing for induction rooms, operating rooms and post ...le in 4 compact models, all providing the basic ha... built-in gas measurement and breath-by-breath ana...
Anesthetists Precordial Kit
Precordial Chestpieces
Medicine Products: